Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

0.2972
+0.00120.41%
Post-market: 0.32100.0238+8.01%19:57 EDT
Volume:4.34M
Turnover:1.29M
Market Cap:7.57M
PE:-0.20
High:0.3095
Open:0.3000
Low:0.2828
Close:0.2960
52wk High:2.05
52wk Low:0.1900
Shares:25.48M
Float Shares:24.18M
Volume Ratio:1.38
T/O Rate:17.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4754
EPS(LYR):-1.1565
ROE:-207.73%
ROA:-89.73%
PB:3.45
PE(LYR):-0.26

Loading ...

BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease

GlobeNewswire
·
Feb 10

BioRestorative Therapies Inc. unveils regenerative medicine pipeline and commercial plans in new investor presentation

Reuters
·
Nov 22, 2025

BioRestorative Therapies files to sell 508,592 shares of common stock for holder

TIPRANKS
·
Nov 19, 2025

BioRestorative Therapies Inc - Type B Meeting Scheduled for Mid-December

THOMSON REUTERS
·
Nov 17, 2025

BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease

GlobeNewswire
·
Nov 17, 2025

BioRestorative Therapies Q3 EPS $(0.33) Beats $(0.36) Estimate, Sales $11.800K Miss $460.000K Estimate

Benzinga
·
Nov 13, 2025

BioRestorative Therapies Q3 Net Income USD -3 Million

THOMSON REUTERS
·
Nov 13, 2025

BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Nov 13, 2025

BioRestorative Therapies Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

BioRestorative Therapies Says Granted Japanese Patent Allowance for Stem Cell Technology; Shares Up Pre-Bell

MT Newswires Live
·
Oct 27, 2025

BioRestorative Therapies Inc - Protected in Developing Alternatives to Glp-1 Drugs

THOMSON REUTERS
·
Oct 27, 2025

BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market

GlobeNewswire
·
Oct 27, 2025

BioRestorative Therapies names Crystal Romano head, global commercial operations

TIPRANKS
·
Oct 22, 2025

BioRestorative Strengthens Commercial Leadership With Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

THOMSON REUTERS
·
Oct 22, 2025

BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit

GlobeNewswire
·
Oct 15, 2025

BioRestorative Therapies announces 1085 million registered direct offering and concurrent private placement of warrants

Reuters
·
Oct 09, 2025

BioRestorative Therapies announces $1.085M registered direct offering

TIPRANKS
·
Oct 07, 2025

BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market

GlobeNewswire
·
Oct 07, 2025